{"id":32595,"date":"2023-07-31T10:56:18","date_gmt":"2023-07-31T16:56:18","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=32595"},"modified":"2023-07-31T10:58:19","modified_gmt":"2023-07-31T16:58:19","slug":"brakke-viewpoint-july-31-2023","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-july-31-2023\/","title":{"rendered":"Brakke Viewpoint 31 de julho de 2023"},"content":{"rendered":"

Not\u00edcias do Vietn\u00e3 esta semana trazem a not\u00edcia da primeira venda comercial de vacina para a peste su\u00edna africana (PSA). Duas novas vacinas foram aprovadas para uso contra esse pat\u00f3geno terr\u00edvel que foi respons\u00e1vel pela morte de at\u00e9 25% da popula\u00e7\u00e3o global de su\u00ednos durante o surto mais recente em 2018\/19.<\/p>\n

Embora a PSA seja conhecida desde o in\u00edcio de 1900, essas parecem ser as primeiras vacinas comerciais disponibilizadas aos produtores. Existem pelo menos 24 gen\u00f3tipos do v\u00edrus da PSA com base no sequenciamento na \u00c1frica e h\u00e1 prote\u00e7\u00e3o cruzada limitada entre diferentes cepas do v\u00edrus. A introdu\u00e7\u00e3o de uma vacina eficaz de amplo espectro seria um divisor de \u00e1guas absoluto para as organiza\u00e7\u00f5es globais de produ\u00e7\u00e3o de su\u00ednos. A estrat\u00e9gia atual para conter um surto de PSA \u00e9 colocar a popula\u00e7\u00e3o su\u00edna em quarentena (se poss\u00edvel) ou abat\u00ea-la.<\/p>\n

O mundo estar\u00e1 atento a evid\u00eancias de efic\u00e1cia no mundo real por parte dessas vacinas. Este \u00e9 um exemplo de como nossa ind\u00fastria contribui para o bem da humanidade atrav\u00e9s dos animais que criamos para alimenta\u00e7\u00e3o; e serve para nos lembrar que ainda pode haver novas solu\u00e7\u00f5es para problemas antigos e intrat\u00e1veis. A ASF lembrou-nos que velhos problemas, at\u00e9 serem resolvidos, t\u00eam sempre potencial para se tornarem novos e potentes desafios.<\/p>\n

Jim Kroman\u00a0 <\/em><\/p>","protected":false},"excerpt":{"rendered":"

Not\u00edcias do Vietn\u00e3 esta semana trazem a not\u00edcia da primeira venda comercial de vacina para a Peste Su\u00edna Africana (PSA). Duas novas vacinas foram aprovadas para utiliza\u00e7\u00e3o contra este terr\u00edvel agente patog\u00e9nico que foi respons\u00e1vel pela morte de at\u00e9 25% da popula\u00e7\u00e3o su\u00edna global durante o surto mais recente em 2018\/19. Embora a PSA seja conhecida desde o in\u00edcio de 1900, estas parecem ser as primeiras vacinas comerciais disponibilizadas aos produtores. Existem pelo menos 24 gen\u00f3tipos do v\u00edrus da PSA baseados na sequencia\u00e7\u00e3o em \u00c1frica e a protec\u00e7\u00e3o cruzada entre diferentes estirpes do v\u00edrus \u00e9 limitada. A introdu\u00e7\u00e3o de uma vacina eficaz de amplo espectro seria uma mudan\u00e7a absoluta para as organiza\u00e7\u00f5es globais de produ\u00e7\u00e3o su\u00edna. A estrat\u00e9gia actual para conter um surto de PSA consiste em colocar a popula\u00e7\u00e3o su\u00edna em quarentena (se poss\u00edvel) ou abat\u00ea-la. O mundo estar\u00e1 atento a evid\u00eancias de efic\u00e1cia no mundo real por parte destas vacinas. Este \u00e9 um exemplo de como a nossa ind\u00fastria contribui para o bem da humanidade atrav\u00e9s dos animais que criamos para alimenta\u00e7\u00e3o; e serve para nos lembrar que ainda pode haver novas solu\u00e7\u00f5es para problemas antigos e intrat\u00e1veis. A ASF lembrou-nos que velhos problemas, at\u00e9 serem resolvidos, t\u00eam sempre o potencial de se tornarem novos e potentes desafios. Jim Croman\u00a0<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[43],"tags":[],"class_list":["post-32595","post","type-post","status-publish","format-standard","hentry","category-viewpoints"],"acf":[],"yoast_head":"\nNews from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-july-31-2023\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"News out of Vietnam this week brings word of the first ever commercial sale of vaccine for African Swine Fever (ASF).\u00a0 Two new vaccines have been approved for use against this dreadful pathogen that was responsible for the deaths of as much as 25% of the global pig population during the most recent outbreak in 2018\/19. Although ASF has been known since the early 1900\u2019s, these appear to be the first ever commercial vaccines made available to producers.\u00a0 There are at least 24 genotypes of ASF virus based on sequencing in Africa and there is limited cross-protection between different strains of the virus.\u00a0 Introduction of an effective broad-spectrum vaccine would be an absolute game-changer for global swine production organizations. Current strategy to contain an ASF outbreak is to either quarantine the pig population (if possible) or slaughter them. The world will be watching for evidence of real-world efficacy on the part of these vaccines.\u00a0 This is an example of what our industry contributes to the good of mankind through animals that we raise for food; and it serves to remind us that there can still be new solutions to old, intractable problems.\u00a0 ASF reminded us that old problems, until solved, always have the potential to become new and potent challenges. Jim Kroman\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-july-31-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-31T16:56:18+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-31T16:58:19+00:00\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"Brakke Viewpoint July 31, 2023\",\"datePublished\":\"2023-07-31T16:56:18+00:00\",\"dateModified\":\"2023-07-31T16:58:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/\"},\"wordCount\":212,\"articleSection\":[\"Viewpoints\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/\",\"url\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"datePublished\":\"2023-07-31T16:56:18+00:00\",\"dateModified\":\"2023-07-31T16:58:19+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Brakke Viewpoint July 31, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-july-31-2023\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"News out of Vietnam this week brings word of the first ever commercial sale of vaccine for African Swine Fever (ASF).\u00a0 Two new vaccines have been approved for use against this dreadful pathogen that was responsible for the deaths of as much as 25% of the global pig population during the most recent outbreak in 2018\/19. Although ASF has been known since the early 1900\u2019s, these appear to be the first ever commercial vaccines made available to producers.\u00a0 There are at least 24 genotypes of ASF virus based on sequencing in Africa and there is limited cross-protection between different strains of the virus.\u00a0 Introduction of an effective broad-spectrum vaccine would be an absolute game-changer for global swine production organizations. Current strategy to contain an ASF outbreak is to either quarantine the pig population (if possible) or slaughter them. The world will be watching for evidence of real-world efficacy on the part of these vaccines.\u00a0 This is an example of what our industry contributes to the good of mankind through animals that we raise for food; and it serves to remind us that there can still be new solutions to old, intractable problems.\u00a0 ASF reminded us that old problems, until solved, always have the potential to become new and potent challenges. Jim Kroman\u00a0","og_url":"https:\/\/brakkeconsulting.com\/pt\/brakke-viewpoint-july-31-2023\/","og_site_name":"Brakke Consulting Website","article_published_time":"2023-07-31T16:56:18+00:00","article_modified_time":"2023-07-31T16:58:19+00:00","author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Amanda McDavid","Tempo estimado de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"Brakke Viewpoint July 31, 2023","datePublished":"2023-07-31T16:56:18+00:00","dateModified":"2023-07-31T16:58:19+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/"},"wordCount":212,"articleSection":["Viewpoints"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/","url":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"datePublished":"2023-07-31T16:56:18+00:00","dateModified":"2023-07-31T16:58:19+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/brakke-viewpoint-july-31-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"Brakke Viewpoint July 31, 2023"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"Amanda McDavid","url":"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/32595","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=32595"}],"version-history":[{"count":1,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/32595\/revisions"}],"predecessor-version":[{"id":32597,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/32595\/revisions\/32597"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=32595"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=32595"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=32595"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}